TMAI · · 17 min read

It’s Coming Home

Trade in Soda and Whisky;

Since 2007, the UK commercial property sector has lagged the market by a wide margin. Many forget that between 2000 and 2007, it was one of the strongest sectors. Over the past five years, the UK Real Estate Investment Trust Universe (REIT) has shrunk from 82 companies to just 39. The core driver throughout has been persistent share price discounts to net asset value, which made listed REITs cheaper to buy than their underlying property.

FTSE REITS vs the FTSE All Share – Including Dividends

Source: Bloomberg

With fixed administration costs and high debt margins covered by less rent, smaller REITs are proportionally more expensive to run. The solution has been for fewer larger REITs, which are more efficient and more liquid. This remarkable change will make this undervalued, high-income sector more appealing for investors.

LondonMetric (LMP) has been the main consolidator, growing its market cap from £291m in 2008 to £4.4bn today by acquiring multiple competitors. Then came the Americans, with Prologis (PLD) scooping up the UK’s largest REIT, Segro (SGRO), for £12.6bn, which is close to book value. So far, the bid has been rejected by the board.

PLD is the second-largest REIT in the US, worth $133 bn. If SGRO is taken private, the largest listed REITs will become Land Securities (LAND), with a market cap of £4.9bn and trading on 0.75x book, and British Land (BLND), with a market cap of £4.3bn and trading on 0.71x book.

What has taken the Americans so long to arrive? I suppose when you are worth 10x the largest UK property stock, the discount didn’t move the dial. But now they are here, and since the tiddlers have been consolidated, more activity will surely follow. If nothing else, there is a catalyst for the deep discounts to be realised.

The Multi-Asset Investor is issued by ByteTree Asset Management Ltd, an appointed representative of Strata Global which is authorised and regulated by the Financial Conduct Authority. ByteTree Asset Management is a wholly owned subsidiary of ByteTree Group Ltd.

General - Your capital is at risk when you invest, never risk more than you can afford to lose. Past performance and forecasts are not reliable indicators of future results. Bid/offer spreads, commissions, fees and other charges can reduce returns from investments. There is no guarantee dividends will be paid. Overseas shares - Some recommendations may be denominated in a currency other than sterling. The return from these may increase or decrease as a result of currency fluctuations. Any dividends will be taxed at source in the country of issue.

Funds - Fund performance relies on the performance of the underlying investments, and there is counterparty default risk which could result in a loss not represented by the underlying investment. Exchange Traded Funds (ETFs) with derivative exposure (leveraged or inverted ETFs) are highly speculative and are not suitable for risk-averse investors.

Bonds - Investing in bonds carries interest rate risk. A bondholder has committed to receiving a fixed rate of return for a fixed period. If the market interest rate rises from the date of the bond's purchase, the bond's price will fall. There is also the risk that the bond issuer could default on their obligations to pay interest as scheduled, or to repay capital at the maturity of the bond.

Taxation - Profits from investments, and any profits from converting cryptocurrency back into fiat currency is subject to capital gains tax. Tax treatment depends on individual circumstances and may be subject to change.

Investment Director: Charlie Morris. Editors or contributors may have an interest in recommendations. Information and opinions expressed do not necessarily reflect the views of other editors/contributors of ByteTree Group Ltd. ByteTree Asset Management (FRN 933150) is an Appointed Representative of Strata Global Ltd (FRN 563834), which is regulated by the Financial Conduct Authority.

© 2026 ByteTree Group Ltd

Read next

AI Drives Genomics
TMAI · The Multi-Asset Investor, TMAI + Quality and Pro tiers

AI Drives Genomics

Trade in Whisky; This week I’ll be revisiting biotech and genomics, but before we get there, I will address